Stay updated on GT90001+Nivolumab in Metastatic HCC Clinical Trial
Sign up to get notified when there's something new on the GT90001+Nivolumab in Metastatic HCC Clinical Trial page.

Latest updates to the GT90001+Nivolumab in Metastatic HCC Clinical Trial page
- CheckyesterdayChange DetectedThe page revision metadata was updated from v3.6.4 to v3.6.5. This reflects a backend/template update for the page and does not affect the displayed study details.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page’s revision label in the footer has been updated to v3.6.4, signaling a behind-the-scenes release update without changes to the displayed study details.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check37 days agoChange DetectedRevision tag updated from v3.6.2 to v3.6.3, representing a minor platform update to the page rather than changes to the study content.SummaryDifference0.1%

- Check44 days agoChange DetectedRevision tag on the page footer was updated from v3.6.0 to v3.6.2, reflecting a minor site maintenance update. The content and study details shown on the page remain unchanged.SummaryDifference0.1%

- Check58 days agoChange DetectedThe study details page adds new user guidance sections and standardizes the Intervention/Treatment header; it also marks recruitment as no longer recruiting and updates the revision to v3.6.0.SummaryDifference0.4%

- Check66 days agoChange DetectedThe page revision stamp was updated from v3.5.4 to v3.5.5, representing a minor version update.SummaryDifference0.1%

Stay in the know with updates to GT90001+Nivolumab in Metastatic HCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GT90001+Nivolumab in Metastatic HCC Clinical Trial page.